Nektar Therapeutics (NKTR): Total Assets
$280.41M
As of 2025-12-31
$1.10B
As of 2026-06-30
-26.7%
3-year compound annual growth
-28.9%
5-year compound annual growth
-5.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $280.41M | -7.7% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $303.85M | -23.7% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $398.03M | -44.0% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $710.60M | -36.4% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $1.12B | -27.4% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $1.54B | -22.2% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $1.98B | -8.0% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $2.15B | +322.5% | 2020-02-28, Balance as of period end |
| 2017-12-31 | $508.87M | -10.5% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $568.87M | +14.1% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $498.64M | +12.9% | 2017-03-01, Balance as of period end |
| 2014-12-31 | $441.62M | +1.6% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $434.53M | -12.7% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $497.79M | -17.9% | 2014-02-27, Balance as of period end |
| 2011-12-31 | $606.55M | +16.4% | 2013-03-01, Balance as of period end |
| 2010-12-31 | $521.23M | n/a | 2012-02-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Nektar Therapeutics (NKTR) | 2025-12-31 | $280.41M | -7.7% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $1.30B | -22.0% |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $61.78M | -33.1% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $105.01M | -15.4% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $808.06M | +76.5% |
| Journey Medical Corp (DERM) | 2025-12-31 | $94.59M | +17.9% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $184.99M | -38.0% |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | $398.69M | +26.0% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $594.82M | +10.0% |
Compare NKTR, AGIO, QTTB, AYTU side by side · Screen every company in Pharmaceutical Preparations ↗